[Analysis of benefits and costs in the eradication of transmissible diseases of endemic character with special reference to poliomyelitis].
Cost-benefit analysis is an important in the rational direction of health policy. The results with respect to poliomyelitis are examined in the light of the money spent and the advantages obtained. It is shown that the cost-benefit ratio has been 1 : 12.98, i.e. every lira spent on vaccination has resulted in a direct saving of 12.98 lire with respect to cases prevented and the cost of their treatment and patient rehabilitation. The ratio is, of course, higher if indirect benefits of a social, moral and occupational kind are included. Some observations are offered on the areas to which cost-benefit analysis can be applied and the ground that it covers.
D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D007279:Injections, Subcutaneous; D007558:Italy; D008297:Male; D011051:Poliomyelitis / Q000453:epidemiology / Q000517:prevention & control*; D011054:Poliovirus Vaccine, Inactivated / Q000008:administration & dosage
D011054:Poliovirus Vaccine, Inactivated
Benefici e costi della eradicazione di malattie trasmissibili a carattere endemico con particolare riferimento alla poliomielite.